Searchable abstracts of presentations at key conferences in endocrinology

ea0020oc2.2 | Diabetes & Obesity | ECE2009

Thymocyte migration is impaired in NOD mice: combined role of extracellular matrix and chemokines

Mendes-da-Cruz Daniella , Bauer Moises , Smaniotto Salete , Keller Alexandre , Savino Wilson , Dardenne Mireille

The NOD (non-obese diabetic) mouse remains the best experimental model of type I diabetes. We have previously described several thymic dysfunctions in these animals, including the presence of giant perivascular spaces (PVS) with arrest of mature T cells (including Treg cells) and partial impairment on fibronectin/VLA-5-dependent NOD thymocyte migration. Herein, we further studied the role of extracellular matrix (ECM) ligands, alone or in combination with the chemokine CXCL12 ...

ea0019p4 | Bone | SFEBES2009

Effects of five gut hormones on osteoblastic-like cell lines

Pacheco-Pantoja EL , Ranganath L , Wilson P , Gallagher J , Fraser WD

Gut hormones are gastro-entero-pancreatic hormones released during the normal physiological response to feeding/fasting. Adequate nutrient intake and normal gastrointestinal function are critical to bone health, which can be under constant repair and remodelling. Gut hormones may integrate a connection between food intake and bone turnover.We studied the effects of five gut hormones, glucose-dependent insulinotropic polypeptide (GIP), glucagon-like pepti...

ea0015p18 | Bone | SFEBES2008

Expression and function of gut hormone receptors in osteoblast cell lines

Pacheco-Pantoja Elda , Wilson Peter , Ranganath Lakshminarayan , James Gallagher , Fraser William

The gastro-entero-pancreatic hormones are involved in the regulation of postprandial nutrient homeostasis. Food intake or fasting triggers the release of these hormones. A direct connection between food intake and bone turnover, assessed by biochemical markers of bone resorption and formation, has been demonstrated in animals and humans.The aim was to study the expression of receptors for the gut hormones, glucose-dependent insulinotropic polypeptide (GI...

ea0015p265 | Pituitary | SFEBES2008

On the origin and nature of big prolactin

English Emma , Beltran Luisa , Mapplebeck Sarah , Smith Thomas , Halsall David , Fahie-Wilson Michael , Ahlquist James

The propensity for prolactin (PRL) to form high molecular mass complexes in serum is well described. Macroprolactin (mPRL), a PRL-immunoglobulin complex (>100 kDa), is the predominant form of PRL in up to 20% of patients with hyperprolactinaemia. Big PRL (bPRL, 40–50 kDa) is a ubiquitous, minor component of serum PRL rarely the major immunoreactive form, the nature of which is unclear. Using gel filtration chromatography (GFC) we have investigated the relative abundan...

ea0011p162 | Clinical case reports | ECE2006

False positive newborn screen for congenital hypothyroidism due to a TSH-IgG (macro-TSH) complex

Halsall DJ , Hall SK , Barker P , Anderson J , Fahie-Wilson M , Gama R , Chatterjee VK

We report a falsely elevated blood spot thyrotrophin (TSH) concentration caused by a TSH-IgG complex. A routine blood spot screen returned a whole blood TSH of 213 mU/l from a one week-old neonate using the Wallac DELFIA method. Measurement in serum confirmed elevated TSH (826 mU/l, Roche Elecsys assay) but free thyroxine (17.2 pmol/l) was normal. The baby’s mother was clinically euthyroid but also showed discordant high serum TSH (287 mU/l) with normal free thyroxine (13...

ea0010p81 | Steroids to include Cushing's | SFE2005

Association of an FC receptor-like 3 haplotype with autoimmune Addison’s disease suggests an alternative pathogenic allele at the locus

Owen C , Eden J , Jennings C , Wilson V , Cheetham T , Pearce S

The common autoimmune endocrinopathies are caused by susceptibility alleles at several genetic loci including MHC, CTLA4, PTPN22 and probably several others. Many of these susceptibility alleles are shared between several different autoimmune disorders including type 1 diabetes, autoimmune thyroid diseases and rheumatoid arthritis. In recent months a novel susceptibility locus was identified in the 5’ end of the Fc receptor-like 3 (FCRL3) gene ...

ea0008p53 | Growth and development | SFE2004

An inducible gene expression model and expression microarray to determine regulators of human pancreatic beta cell differentiation

Dunleavey L , Piper K , Custard E , Worley H , Packham GK , Wilson DI , Hanley NA

Understanding human pancreatic beta cell differentiation provides safe, normal pathways by which to manipulate stem cells for the ambitious treatment of Type 1 diabetes (1-3). The transcription factor Neurogenin 3 (Ngn3) is a transient, yet critical regulator of this process, committing progenitor cells to an endocrine cell fate (4). However, the downstream consequences of NGN3 expression remain incompletely understood.To identify new target genes of NGN...

ea0007p173 | Reproduction | BES2004

Specificity and clinical utility of methods for the detection of macroprolactin

Smith T , Gibney J , Kavanagh L , Fahie-Wilson M , McKenna T

Where screening for macroprolactin takes place, laboratories routinely rely on treatment of sera with polyethylene glycol (PEG) to distinguish macroprolactinaemia from true hyperprolactinaemia. However, PEG causes significant interference in some immunoassays and furthermore leads to co-precipitation of a variable amount of monomeric prolactin in addition to macroprolactin in treated sera. The aim of this study was to assess the specificity and clinical utility of alternative ...

ea0003p64 | Clinical Case Reports | BES2002

Prolactinoma and macroprolactin

Fayers K , Cox S , Bower L , Dyer R , Dearman G , Fahie-Wilson M

Macroprolactin(mPRL)is a high molecular weight form of prolactin(PRL)most commonly due to formation of a complex with IgG.The PRL in mPRL remains reactive in immunoassays for PRL and the complex has a longer plasma half life than monomeric PRL.mPRL is a common cause of hyperprolactinaemia but its origin is not known and the complex has minimal bioactivity in vivo.The clinical significance of hyperprolactinaemia due to mPRL is that it can cause diagnostic confusion and lead to ...

ea0045oc7.2 | Oral Communications 7- Diabetes | BSPED2016

The development of an e-learning package to support education staff with the management of type 1 diabetes

Williams Matt , Wilson Kate , Acerini Carlo , O'Hickey Elaine , Haest Jane , Singleton Sandra , Carson Margot , Nelson Helena

Currently in the UK children and young people with diabetes receive variable provision of care and support in educational settings. There are concerns that this impacts on the young person’s glycaemic control, their quality of life, and their educational performance and outcome. Whilst most paediatric diabetes teams provide training for school staff, it may take several days, even weeks, after diagnosis before a diabetes educator is able to attend the school to provide ed...